天眼查App显示,2025-10-17,“抗柯萨奇病毒A16型的抗体及其制备方法和应用”(patentName)正式进入专利权的授权阶段。申请人为北京民海生物科技有限公司,该项生物医药专利涉及抗柯萨奇病毒A16型(CV-A16)的抗体研发与应用。据专利信息显示,该抗体或其抗原结合片段可特异性结合并中和CV-A16毒株及其抗原,对CV-A16感染动物具有良好的保护作用,技术效果数据提升达显著优化。...
Source Link天眼查App显示,2025-10-17,“抗柯萨奇病毒A16型的抗体及其制备方法和应用”(patentName)正式进入专利权的授权阶段。申请人为北京民海生物科技有限公司,该项生物医药专利涉及抗柯萨奇病毒A16型(CV-A16)的抗体研发与应用。据专利信息显示,该抗体或其抗原结合片段可特异性结合并中和CV-A16毒株及其抗原,对CV-A16感染动物具有良好的保护作用,技术效果数据提升达显著优化。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.